Emergency treatment in glutaryl-CoA dehydrogenase deficiency

Journal of Inherited Metabolic Disease

Volumn 27, Issue 6, 2004, Pages 893-902

  Kolker S ^a   Greenberg, C R ^b   Lindner, M ^a   Muller E ^a   Naughten, E R ^c   Hoffmann, Georg F ^a  

^a UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

^b UNIVERSITY OF MANITOBA   (Canada)

^c CHILDREN S UNIVERSITY HOSPITAL   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; ANTICONVULSIVE AGENT; ANTIEMETIC AGENT; ANTIPYRETIC AGENT; BICARBONATE; CARNITINE; DIURETIC AGENT; ELECTROLYTE; FUROSEMIDE; GLUCOSE; GLUTARYL COENZYME A DEHYDROGENASE; INSULIN; LIPID; LYSINE; MALTODEXTRIN; ONDANSETRON; PHENOBARBITAL; PHENYTOIN; RIBOFLAVIN; VACCINE;

ACIDOSIS; ACUTE DISEASE; ASPIRATION; BRAIN DISEASE; CATABOLISM; CAUSE OF DEATH; CHILD; CHOREOATHETOSIS; DIET THERAPY; DYSKINESIA; DYSTONIA; EMERGENCY TREATMENT; ENZYME DEFICIENCY; EXTRAPYRAMIDAL SYNDROME; FAILURE TO THRIVE; FEEDING DISORDER; FEVER; HOSPITAL CARE; HUMAN; IMMOBILIZATION; MAINTENANCE THERAPY; MOTOR DYSFUNCTION; OUTPATIENT CARE; PEDIATRIC SURGERY; PROTEIN RESTRICTION; PUTAMEN; RECURRENT DISEASE; REVIEW; SEIZURE; SPEECH DISORDER; VACCINATION; VOMITING;

AMINO ACID METABOLISM, INBORN ERRORS; BASAL GANGLIA DISEASES; EMERGENCY MEDICAL SERVICES; GLUTARYL-COA DEHYDROGENASE; HUMANS; OXIDOREDUCTASES ACTING ON CH-CH GROUP DONORS;

EID: 7244240722     PISSN: 01418955     EISSN: None     Source Type: Journal    
DOI: 10.1023/B:BOLI.0000045774.51260.ea     Document Type: Review

References (28)

1. Bjugstad KB, Goodman SI, Freed CR (2000) Age at symptom onset predicts severity of motor impairment and clinical outcome of glutaric acidemia type I. J Pediatr 137: 681-686.
2. Bodamer OA, Hoffmann GF, Visser GH, et al (1997) Assessment of energy expenditure in metabolic disorders. Eur J Pediatr 156 (supplement 1): S24-28.
3. Brismar J, Ozand PT (1995) CT and MR of the brain in glutaric aciduria type I: A review of 59 published cases and a report of 5 new patients. Am J Neuroradiol 16: 675-683.
4. Busquets C, Merinero B, Christensen E, et al (2000) Glutaryl-CoA dehydrogenase deficiency in Spain: Evidence of two groups of patients, genetically, and biochemically distinct. Pediatr Res 48: 315-322.
5. D-A-CH (Deutsche Gesellschaft für Ernährung, Österreichische Gesellschaft für Ernährung, Schweizerische Gesellschaft für Ernährungsforschung, Schweizerische Vereinigung für Ernährung) (2000) Referenzwerte für die Nährstoffzufuhr. Frankfurt: Umschau/Braus.
6. Desai NK, Runge VM, Crisp DE, Crisp MB, Naul LG (2003) Magnetic resonance imaging of the brain in glutaric acidemia type I. Invest Radiol 38: 489-496.
7. Elster AW (2004) Glutaric aciduria type I. Value of diffusion-weighted magnetic resonance imaging for diagnosing acute striatal necrosis. J Comput Assist Tomogr 28: 98-100.
8. Feillet F, Bodamer OA, Dixon MA, Sequeira S, Leonard JV (2000) Resting energy expenditure in disorders of propionate metabolism. J Pediatr 136: 659-663.
9. Greenberg CR, Prasad AN, Dilling LA, et al (2002) Outcome of the first three years of a DNA-based neonatal screening program for glutaric acidemia type 1 in Manitoba and Northwestern Ontario, Canada. Mol Gen Metabol 75: 70-78.
10. Hoffmann GF, Athanassopoulos S, Burlina AB, et al (1996) Clinical course, early diagnosis, treatment, and prevention of disease in glutaryl-CoA dehydrogenase deficiency. Neuropediatrics 27: 115-123.
11. Institute of Medicine of the National Academy (2002) Dietary Reference Intakes (DRI) for Energy, Carbohydrate, Fiber, Fat, Fatty Acids, Cholesterol, Protein and Amino Acids. Washington, DC: Food and Nutrition Board; The National Academies Press.
12. Koeller DM, Sauer S, Wajner M, et al (2004) Animal models for glutaryl-CoA dehydrogenase deficiency. J Inherit Metab Dis 27 813-818.
13. Kölker S, Schwab MA, Hörster F, et al (2003) Methylmalonic acid, a biochemical hallmark of methylmalonic acidurias but no inhibitor of mitochondrial respiratory chain. J Biol Chem 278: 47388-47393.
14. Kölker S, Koeller DM, Sauer S, et al (2004) Excitotoxicity and bioenergetics in glutaryl-CoA dehydrogenase deficiency. J Inherit Metab Dis 27: 805-812.
15. Kyllerman M, Skjeldal O, Christensen E, et al (2004) Long-term follow-up, neurological outcome and survival rate in 28 Nordic patients with glutaric aciduria type 1. Eur J Paediatr Neural 8: 121-129.
16. Monavari AA, Naughten ER (2000) Prevention of cerebral palsy in glutaric aciduria type 1 by dietary management. Arch Dis Child 82: 67-70.
17. Mühlhausen C, Hoffmann GF, Strauss KA, et al (2004a) Maintenance treatment in glutaryl-CoA dehydrogenase deficiency. J Inherit Metab Dis 27: 885-892.
18. Mühlhausen C, Ergün S, Strauss KA, et al (2004b) Vascular dysfunction as an additional pathomechanism in glutaric aciduria type I. J Inherit Metab Dis 27: 829-834.
19. Naughten ER, Mayne PD, Monavari AA, et al (2004) Glutaric aciduria type I: Outcome in the Republic of Ireland. J Inherit Metab Dis 27 917-920.
20. Neumaier-Probst E, Harting I, Seitz A, Ding C, Kolker S (2004) Neuroradiologic findings in glutaric aciduria type I (glutaryl-CoA dehydrogenase deficiency). J Inherit Metab Dis 27: 869-876.
21. Nyhan WL, Rice-Kelts M, Klein J, Barshop BA (1998) Treatment of acute crisis in maple syrup urine disease. Arch Pediatr Adolesc Med 152: 593-598.
22. Okun JG, Hörster F, Farkas LM, et al (2002) Neurodegeneration in methylmalonic aciduria involves inhibition of complex II and tricarboxylic acid cycle, and synergistically acting excitotoxicity. J Biol Chem 277: 14674-14680.
23. Prietsch V, Lindner M, Zschocke J, Nyhan WL, Hoffmann GF (2002) Emergency management of inherited metabolic diseases. J Inherit Metab Dis 25: 531-546.
24. Strauss KA, Puffenberger EG, Robinson DL, Morton DH (2003) Type I glutaric aciduria, part 1: Natural history of 77 patients. Am J Med Genet 121C: 38-52.
25. Twomey EL, Naughten ER, Donogue VB, Ryan S (2003) Neuroimaging findings in glutaric aciduria type 1. Pediatr Radiol 33: 823-830.
26. Varadkar S, Surtees R (2004) Glutaric aciduria type I and kynurenine pathway metabolites: A modified hypothesis. J Inherit Metab Dis 27: 835-842.
27. Wajner M, Kölker S, Souza DO, Hoffmann GF, de Mello CF (2004) Modulation of glutamatergic and GABAergic neurotransmission in glutaryl-CoA dehydrogenase deficiency. J Inherit Metab Dis 27 825-828.
28. Wendel U, Langenbeck U, Lombeck I, Bremer HJ (1982) Maple syrup urine disease - therapeutic use of insulin in catabolic states. Eur J Pediatr 139: 172-175.